Bridging The Sickle Cell Survival Gap In Nigeria

For millions of Nigerians living with sickle cell disease (SCD), access to timely diagnosis, treatment and quality healthcare remains a daily struggle.

Despite advances in medical science, many patients continue to face barriers that reduce their chances of survival and limit their quality of life.

As the world marked the 2026 World Sickle Cell Day, themed: “Closing the Survival Gap: Equity in Sickle Cell Care,” the federal government used the occasion to reaffirm its commitment to changing this reality through policies and interventions aimed at ensuring that every Nigerian living with the condition receives quality care, regardless of where they live or their economic status.

The Coordinating Minister of Health and Social Welfare, Prof. Muhammad Ali Pate, described sickle cell disease as one of Nigeria’s most pressing public health challenges.

The minister noted that Nigeria bears the highest burden of sickle cell disease globally, with about 25 per cent of adults carrying the sickle cell gene. Even more alarming, he revealed that an estimated 100,000 infants die annually from complications associated with the disease.

“Despite advances in medical science, many Nigerians living with sickle cell disease continue to face significant barriers to diagnosis, treatment and quality healthcare services, resulting in avoidable deaths and reduced quality of life,” he said.

The Director of Public Health at the ministry,  Dr Charles Nzelu, said only about 50 per cent of children born with sickle cell disease survive beyond the age of five.

The statistics underscore the urgent need for stronger prevention programmes, early diagnosis and improved treatment services.

Dr Nzelu urged Nigerians to know their genotype before marriage and seek genetic counselling to make informed decisions.

“The best way to control the disease is prevention,” he stressed.

The call reflects years of advocacy by healthcare professionals who believe widespread awareness and genotype testing could significantly reduce the number of children born with the disease.

However, the federal government said it is implementing several interventions aimed at improving survival outcomes and reducing inequalities in access to care.

One of the flagship initiatives is the implementation of the Universal Newborn Screening Policy for Sickle Cell Disease in selected healthcare facilities across Lagos State, Kano State and the Federal Capital Territory, with support from the Clinton Health Access Initiative (CHAI).

The programme seeks to identify affected babies shortly after birth, allowing healthcare providers to begin treatment and monitoring before complications arise.

The Federal Ministry of Health has also reviewed the National Guidelines for the Prevention, Control and Management of Sickle Cell Disease to promote evidence-based interventions, including wider use of Hydroxyurea therapy, a medication proven to reduce painful crises and improve survival.

To support implementation, the ministry revealed that healthcare workers are currently being trained, beginning with the South-West geopolitical zone, with plans to expand the programme nationwide.

The Director, Centre of Excellence for Sickle Cell Disease Research and Training at the University of Abuja and Special Adviser to the Minister on Sickle Cell Disease, Prof. Obiageli Nnodu,

disclosed that researchers have screened more than 38,000 babies in the Federal Capital Territory.

According to her, more than 700 genetic counsellors have been trained across the country, while efforts are ongoing to increase the uptake of Hydroxyurea therapy among patients.

These initiatives are helping to strengthen evidence-based decision-making and position Nigeria as a leader in sickle cell disease research and treatment in Africa.

Meanwhile, for many people living with sickle cell disease, the challenge extends beyond managing painful symptoms and frequent hospital visits.

Stigma, discrimination and misconceptions continue to affect their social relationships, education and employment opportunities.

Recognising this, Prof. Pate called on Nigerians to support people living with sickle cell disease and help eliminate the stigma associated with the condition.

For the thousands of children born with sickle cell disease every year, the promise of equitable access to diagnosis, treatment and lifelong care could mean the difference between survival and premature death.